Recruiting exceptional talent and driving innovative technology is the Canary way. Help us continue making both a priority by investing in our mission.
Canary is the world’s only non-profit focused solely on early cancer detection. We have multidisciplinary science teams focused on blood-based biomarkers or biological ‘fingerprints’ that show the presence or progress of disease. We’re pairing those biomarkers with advanced imaging technologies that will help us visualize a cancer type with more sensitivity and specificity.
Our clinical programs cover tumors across five cancer types: breast, lung, ovarian, pancreas, and prostate. And to further ensure our success, we funded the Canary Center at Stanford for Cancer Early Detection, a worldclass facility that hopes to save lives through early detection. We also have a center of excellence in early cancer detection at the Fred Hutchinson Cancer Research Center in Seattle. The ‘HUTCH’ as it’s called was the genesis for the Canary Foundation.
Here’s to a world in which cancer can be detected with an easy test, early enough that it can be wiped out quickly with minimal side effects.
